Saturday, June 6, 2026

From Diplomacy to Defiance: North Korea’s Satellite Launch Amidst Trilateral Talks

Although the three countries, South Korea, China,...

How Hippocrat Labs Achieved 4 ISO Certifications: A Game Changer for Digital Healthcare in 2026

Hippocrat Labs secures four ISO certifications for information security, enhancing healthcare data protection amid rising cyber threats.

YOUR DATA IS GONE: NYSE-Listed Coupang Leaked 33 Million Accounts—And You Did Not Know It

Coupang faces class-action lawsuits after a data breach affecting 33.7 million accounts, with actions planned in the U.S. and Korea.

Tag: ADC

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

How Dong-A ST’s SC5024 and ADC Innovations Could Change the Game Cancer Pipeline

Dong-A ST showcased its innovative cancer pipeline at AACR 2026, featuring promising preclinical findings and advanced therapeutic strategies.

Unlocking Cancer Treatment: Celltrion’s 4 Promising ADC Drugs Enter Patient Trials in 2026

Celltrion's ADC cancer drug candidates CT-P70, CT-P71, and CT-P73 enter patient dosing, targeting various cancers with Fast Track Designation.

CT-P71: The New ADC Cancer Drug Fast-Tracked by FDA for Urothelial Carcinoma

Celltrion's CT-P71 receives FDA Fast Track designation for urothelial carcinoma, enhancing its ADC pipeline and global drug development efforts.

ABL Bio to Invest Additional $25 Million in Neok Bio to Accelerate ADC Clinical Trials

ABL Bio invests $25M in Neok Bio for bispecific antibody-drug conjugate trials, aiming for FDA-approved treatments by 2027.

ABL209 Receives FDA Approval: What This Dual Antibody ADC Means for Cancer Treatment

ABL Bio receives FDA approval for ABL209, a bispecific antibody-drug conjugate, advancing ADC development for solid tumors.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.